BROWNING; Jeffrey L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BROWNING; Jeffrey L..The latest application filed is for "treatment of autoimmune disorders".

Company Profile

0.22.26

BROWNING; Jeffrey L. - Brookline MA
BROWNING; Jeffrey L. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Autoimmune Disorders App 20130259861 - BECKMAN; Evan ; et al.	2013-10-03
Ltbr Blockade: Methods For Optimizing Therapeutic Responsiveness Of Patients App 20130216557 - Bienkowska; Jadwiga ; et al.	2013-08-22
Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification App 20130196376 - Browning; Jeffrey L. ; et al.	2013-08-01
Methods for inhibiting lymphotoxin-.beta. receptor signaling in TH1 cell-associated disorders Grant 8,455,445 - Browning , et al. June 4, 2	2013-06-04
Compositions comprising variant LT-B-R-IG fusion proteins Grant 8,338,376 - Beckman , et al. December 25, 2	2012-12-25
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Grant 8,287,874 - Browning , et al. October 16, 2	2012-10-16
Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins Grant 8,283,138 - Browning , et al. October 9, 2	2012-10-09
Treatment Of Demyelinating Disorders With Soluble Lymphotoxin-beta-receptor App 20120244153 - BROWNING; Jeffrey L. ; et al.	2012-09-27
Soluble Lymphotoxin-beta Receptors And Anti-lymphotoxin Receptor And Ligand Antibodies As Therapeutic Agents For The Treatment Of Immunological Diseases App 20120156214 - BROWNING; Jeffrey L. ; et al.	2012-06-21
Treatment of demyelinating disorders with soluble lymphotoxin-.beta.-receptor Grant 8,067,375 - Browning , et al. November 29, 2	2011-11-29
Soluble Lymphotoxin-beta Receptor Fusion Protein And Methods For Inhibiting Lymphotoxin Beta-receptor Signaling App 20110250200 - BROWNING; Jeffrey L. ; et al.	2011-10-13
Soluble lymphotoxin-.beta. receptor fusion protein and methods for inhibiting lymphotoxin .beta.-receptor signaling Grant 7,951,371 - Browning , et al. May 31, 2	2011-05-31
Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents Grant 7,947,271 - Browning , et al. May 24, 2	2011-05-24
TAJ in Neuronal Function App 20110052500 - Mi; Sha ; et al.	2011-03-03
Soluble Lymphotoxin-beta Receptor Fusion Protein And Methods For Inhibiting Lymphotoxin Beta-receptor Signaling App 20110046073 - Browning; Jeffrey L. ; et al.	2011-02-24
Methods of promoting neurite outgrowth with soluble TAJ polypeptides Grant 7,846,438 - Mi , et al. December 7, 2	2010-12-07
Receptor Coupling Agents And Therapeutic Uses Thereof App 20100266542 - BROWNING; Jeffrey L. ; et al.	2010-10-21
Receptor coupling agents and compositions thereof Grant 7,799,902 - Browning , et al. September 21, 2	2010-09-21
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Grant 7,744,891 - Browning , et al. June 29, 2	2010-06-29
Treatment Of Autoimmune Disorders App 20100111952 - Beckman; Evan ; et al.	2010-05-06
Treatment Of Demyelinating Disorders With Soluble Lymphotoxin-beta-receptor App 20100099608 - BROWNING; Jeffrey L.	2010-04-22
Treatment of follicular lymphomas using inhibitors of the LT pathway Grant 7,618,933 - Browning , et al. November 17, 2	2009-11-17
Anti-lymphotoxin-beta Receptor Antibodies As Anti-tumor Agents App 20090123421 - Browning; Jeffrey L. ; et al.	2009-05-14
Anti-lymphotoxin-.beta. receptor antibodies as anti-tumor agents Grant 7,459,537 - Browning , et al. December 2, 2	2008-12-02
Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway Grant 7,452,530 - Browning , et al. November 18, 2	2008-11-18
Methods for inhibiting lymphotoxin .beta. receptor signalling Grant 7,427,403 - Browning , et al. September 23, 2	2008-09-23
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases App 20080219967 - Browning; Jeffrey L. ; et al.	2008-09-11
Soluble lymphotoxin-.beta. receptors as therapeutic agents for the treatment of systemic lupus erythematosus Grant 7,309,492 - Browning , et al. December 18, 2	2007-12-18
Use of lymphotoxin-.beta. receptor blocking agents for the treatment of antibody mediated immunological diseases Grant 7,255,854 - Browning , et al. August 14, 2	2007-08-14
Receptor coupling agents and therapeutic uses thereof App 20070154476 - Browning; Jeffrey L. ; et al.	2007-07-05
Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof App 20070116668 - Browning; Jeffrey L. ; et al.	2007-05-24
Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof App 20060104971 - Garber; Ellen ; et al.	2006-05-18
TAJ in neuronal function App 20060058223 - Mi; Sha ; et al.	2006-03-16
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents Grant 7,001,598 - Browning , et al. February 21, 2	2006-02-21
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents App 20050281811 - Browning, Jeffrey L. ; et al.	2005-12-22
Methods for inhibiting lymphotoxin beta receptor signalling App 20050037003 - Browning, Jeffrey L. ; et al.	2005-02-17
Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway App 20040198635 - Browning, Jeffrey L. ; et al.	2004-10-07
Soluble lymphotoxin-.beta. receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease Grant 6,669,941 - Browning , et al. December 30, 2	2003-12-30
Novel nuclear factor polypeptides and nucleic acids encoding same App 20030148935 - Peyman, John A. ; et al.	2003-08-07
Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof App 20030143210 - Browning, Jeffrey L. ; et al.	2003-07-31
Soluble lymphotoxin beta receptor and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for treatment App 20020197254 - Browning, Jeffrey L. ; et al.	2002-12-26
Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents App 20020090366 - Browning, Jeffrey L. ; et al.	2002-07-11
Soluble lymphotoxin-.beta. receptors as therapeutic agents for the treatment of immunological disease Grant 6,403,087 - Browning , et al. June 11, 2	2002-06-11
Lymphotoxin-.alpha./.beta. complexes and anti-lympotoxin-.beta. receptor antibodies as anti-tumor agents Grant 6,312,691 - Browning , et al. November 6, 2	2001-11-06
Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease Grant 5,925,351 - Browning , et al. July 20, 1	1999-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.